期刊
INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
卷 67, 期 17, 页码 1028-1049出版社
TAYLOR & FRANCIS AS
DOI: 10.1080/00914037.2017.1405350
关键词
Cancer therapy; drug delivery; nanoparticles; poly(lactic-co-glycolic acid); targeting
Among all polymers, without doubt, poly(lactic-co-glycolic acid) (PLGA) is the most popular one in biology and biomedicine fields. Having a tunable structure, a controllable and desired release profile, huge capacity of functionalization with various agents besides an incredible biosafety and biocompatibility, which led to its food and drug administration (FDA) approval, is among some outstanding features of this polymer. Cancer treatment using PLGA-based vehicles carrying anticancer agents, delivery of various active compounds from drugs to peptides and vaccines, tissue regeneration, and treatment of central nervous system disorders, all shows the potential of this polymer in this area. Nowadays, the focus of most investigations is on designing the most efficient PLGA formulation and improving its effectiveness with various synthesis and postsynthesis modifications. The aim of this review is to mention some recent investigations directed to improve PLGA efficiency in biomedical area. [GRAPHICS] .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据